Home › About Us › Our Staff › Turna Ray

Turna Ray

Senior Editor
Phone Number
+1-212-651-5626
Email
tray@genomeweb.com

Turna Ray has been covering the personalized medicine and molecular diagnostics industries for GenomeWeb since 2006. She closely tracks the evolving regulatory, reimbursement, and business environment for precision medicine products. 

Articles Authored by Turna Ray

Jul 18, 2018

Study Reports Fewer Dose Adjustments With PGx-Guided Warfarin Versus Standard Care in Asian Patients

Premium

The study, involving 322 patients from China, India, and Malaysia, is the largest randomized evaluation of warfarin PGx in Asian patients, the authors said.

Jul 12, 2018

Sight Diagnostics Launches POC System for Complete Blood Count in Europe With Plans for US Market

Premium

Having achieved CE marking, the new OLO system has launched in Europe and non-US countries, while the company is conducting studies necessary for US FDA clearance.

Jul 03, 2018

In Williams v Quest, State Supreme Court Leaves Room for Plaintiff to Argue Ordinary Negligence

Though the South Carolina Supreme Court said Quest was a healthcare provider, Williams can try to keep her case alive by arguing she's alleging ordinary negligence.

Jun 22, 2018

Some Stakeholders Not on Board With Draft Bill on New Dx Regulatory Framework

Premium

Seventeen organizations don't support the Diagnostic Accuracy and Innovation Act as written and would like lawmakers to advance a CLIA-centric framework.


Jun 20, 2018

Merck KGaA Advancing Tepotinib in MET-Altered Cancer Subpopulations

Premium

The German drugmaker plans to advance the NSCLC treatment in parallel with tissue-based and liquid biopsy companion assays that can identify best responders.

Jun 14, 2018

Janssen Plans Year-End Erdafitinib Filing Based on Phase II Data in FGFR-Mutated Bladder Cancer

Premium

The company is planning to submit the drug and a companion diagnostic that can identify patients with FGFR alterations with the FDA in the second half of 2018.

May 30, 2018

Stakeholders Urge Payors to Cover Confirmatory Testing for 23andMe's DTC BRCA Test

Premium

The Center for Genomic Interpretation and NSGC want payors to cover confirmatory testing for patients with positive results from 23andMe's FDA-cleared test.

May 29, 2018

Myriad Genetics Adds Reproductive Tests With Counsyl Buy, Lessens Hereditary Cancer Competition

Premium

The $375 million deal marks the integration of Myriad, a leader in the hereditary cancer genetic screening market, with Counsyl, a leader in reproductive genetic screening.

May 23, 2018

Public Awareness of Personalized Medicine Not Growing in Step With Industry, Survey Shows

Although people have greater access to personalized drugs and tests than ever before, a survey by GenomeWeb and the PMC shows public awareness isn't improving.  

May 22, 2018

Genomind Adds Utility Evidence for Mental Illness PGx Test in Bid to Increase Payor Acceptance

Premium

While a randomized-controlled trial is underway, Genomind hopes data from a new case-control study will convince insurers its PGx test can reduce healthcare utilization costs.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.